BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.65
−0.82%0
Insider buys (3m)
11
Insider sells (3m)
-$60.5K
Net value (3m)
-7.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | A-Award | 60,000 | $4.21 |
| Jul 17, 2026 | Skynner Michael · officer: CHIEF SCIENTIFIC OFFICER | A-Award | 60,000 | $4.21 |
| Jul 17, 2026 | Hannay Michael Charles Ferguson · officer: CHIEF PROD & SUPPLY CHAIN OFF | A-Award | 60,000 | $4.21 |
| Jul 17, 2026 | Thompson Travis Alvin · officer: Chief Financial Officer | A-Award | 60,000 | $4.21 |
| Jul 7, 2026 | Lee Kevin · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,737 | $4.31 |
| Jul 7, 2026 | Thompson Travis Alvin · officer: Chief Financial Officer | Sale | 104 | $4.31 |
| Jul 7, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | Sale | 333 | $4.34 |
| Jul 7, 2026 | Skynner Michael · officer: CHIEF SCIENTIFIC OFFICER | Sale | 1,859 | $4.27 |
| Jul 7, 2026 | Skynner Michael · officer: CHIEF SCIENTIFIC OFFICER | Sale | 532 | $4.31 |
| Jul 7, 2026 | Hannay Michael Charles Ferguson · officer: CHIEF PROD & SUPPLY CHAIN OFF | Sale | 1,506 | $4.27 |
| Jul 7, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | Sale | 43 | $4.31 |
| Jul 7, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | Sale | 1,036 | $4.27 |
| Jul 7, 2026 | Thompson Travis Alvin · officer: Chief Financial Officer | Sale | 819 | $4.27 |
| Jul 7, 2026 | Hannay Michael Charles Ferguson · officer: CHIEF PROD & SUPPLY CHAIN OFF | Sale | 255 | $4.31 |
| Jul 7, 2026 | Lee Kevin · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 5,905 | $4.27 |
| Apr 6, 2026 | Hannay Michael Charles Ferguson · officer: CHIEF PROD & SUPPLY CHAIN OFF | Sale | 1,521 | $4.91 |
| Apr 6, 2026 | Thompson Travis Alvin · officer: Chief Financial Officer | Sale | 799 | $4.91 |
| Apr 6, 2026 | Hannay Michael Charles Ferguson · officer: CHIEF PROD & SUPPLY CHAIN OFF | Sale | 251 | $5.05 |
| Apr 6, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | Sale | 37 | $5.05 |
| Apr 6, 2026 | Lee Kevin · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 1,716 | $5.05 |
| Apr 6, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | Sale | 333 | $5.04 |
| Apr 6, 2026 | Skynner Michael · officer: CHIEF SCIENTIFIC OFFICER | Sale | 1,879 | $4.91 |
| Apr 6, 2026 | Skynner Michael · officer: CHIEF SCIENTIFIC OFFICER | Sale | 525 | $5.05 |
| Apr 6, 2026 | Lee Kevin · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 5,967 | $4.91 |
| Apr 6, 2026 | Thompson Travis Alvin · officer: Chief Financial Officer | Sale | 102 | $5.05 |
| Apr 6, 2026 | Perry Jennifer Scott · officer: Chief Operating Officer | Sale | 1,038 | $4.91 |
| Feb 4, 2026 | Thompson Travis Alvin · officer: Chief Financial Officer | A-Award | 58,000 | $6.49 |
| Jan 6, 2026 | Milnes Alistair · officer: CHIEF OPERATING OFFICER | Sale | 3,244 | $6.80 |
| Jan 6, 2026 | DANSEY ROGER D · director | A-Award | 3,032 | $0.00 |
| Jan 6, 2026 | Milnes Alistair · officer: CHIEF OPERATING OFFICER | A-Award | 50,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 34Increased 78Reduced 35Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Unchanged | 10,885,357 | Aug 14, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 10,885,357 | May 15, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3,468,430 | Aug 14, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3,468,430 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 3,398,000 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Unchanged | 3,398,000 | Aug 14, 2026 |
| Long Focus Capital Management, LLC | Unchanged | 3,310,687 | Aug 14, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | Increased | 3,310,687 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Unchanged | 1,968,025 | Aug 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,968,025 | May 13, 2026 |
| SIREN, L.L.C. | Reduced | 1,560,882 | May 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 1,533,400 | Aug 13, 2026 |
| GSK PLC | Unchanged | 1,529,561 | May 14, 2026 |
| GSK plc | Unchanged | 1,529,561 | Aug 13, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | Increased | 1,174,625 | May 4, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 17, 2026